Loading...

Bio Business

» nonprofit, tuberculosis and drug development

Most Recent

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By Catherine Offord | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By Jenny Rood | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

image: The Growth of Iowa Biotech

The Growth of Iowa Biotech

By Jenny Rood | August 1, 2016

The state’s industry draws inspiration from medicine as well as agriculture.

1 Comment

image: Desperately Seeking Shut-Eye

Desperately Seeking Shut-Eye

By Anna Azvolinsky | March 1, 2016

New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By Kate Yandell | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: Battling the Bulge

Battling the Bulge

By Bob Grant | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

0 Comments

image: The Sounds of Silence

The Sounds of Silence

By Jenny Rood | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

4 Comments

image: Lazarus Drugs

Lazarus Drugs

By Kate Yandell | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

image: Cannabis Biotech

Cannabis Biotech

By Daniel Cossins | December 1, 2014

As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.

2 Comments

Popular Now

  1. Salk Institute Suspends Cancer Scientist Inder Verma
  2. Long-Term Study Reveals Flip in Plant Responses to Carbon Dioxide
  3. Jim Bridenstine Confirmed to Lead NASA
  4. RNA Injection Restores Hearing in Guinea Pigs